Last update 20 Feb 2025
Hubei Sihuan Pharmaceutical Co Ltd.

Hubei Sihuan Pharmaceutical Co Ltd.

Private Company | Subsidiary Company|
2002|
Hubei Sheng, China
|
www.hbsh.cn

Overview

Tags

Skin and Musculoskeletal Diseases
Endocrinology and Metabolic Disease
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug1

Related

1
Drugs associated with Hubei Sihuan Pharmaceutical Co Ltd.
Ipriflavone
Target-
Mechanism
Osteoclasts inhibitors
Active Org.
Hubei Sihuan Pharmaceutical Co Ltd.Hubei Sihuan Pharmaceutical Co Ltd.
Originator Org.-
Active Indication
Osteoporosis
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date01 Jan 2001
1
Clinical Trials associated with Hubei Sihuan Pharmaceutical Co Ltd.
CTR20191149
/ CompletedNot Applicable
盐酸曲美他嗪片健康志愿者单中心、开放、均衡、随机、单剂量、双周期、双交叉空腹和餐后的生物等效性试验
[Translation] A single-center, open, balanced, randomized, single-dose, two-period, double-crossover bioequivalence study of trimetazidine hydrochloride tablets in healthy volunteers on fasting and fed diet
100 Clinical Results associated with Hubei Sihuan Pharmaceutical Co Ltd.
Login to view more data
0 Patents (Medical) associated with Hubei Sihuan Pharmaceutical Co Ltd.
Login to view more data
100 Deals associated with Hubei Sihuan Pharmaceutical Co Ltd.
Login to view more data
100 Translational Medicine associated with Hubei Sihuan Pharmaceutical Co Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Ipriflavone
Osteoporosis
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free